Who is sponsoring NCT03765034?

NCT03765034 is sponsored by Children's Hospital Los Angeles.

What drugs are being tested in NCT03765034?

Interventions in NCT03765034: Constrain-induced Movement Therapy, Usual Occupational Therapy.

What condition does NCT03765034 study?

NCT03765034 studies Neonatal Brachial Plexus Palsy.

Is NCT03765034 still recruiting?

NCT03765034 is currently completed. Last updated 5 December 2018.

Last reviewed 2018-12-05 · How we verify

NCT03765034

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Constraint-induced Movement Therapy for Perinatal Brachial Plexus Injury

Completed NA Last updated 5 December 2018

What this trial tests

NA trial testing Constrain-induced Movement Therapy in Neonatal Brachial Plexus Palsy in 22 participants. Completed in 31 December 2014.

Timeline

1 January 2010

Primary endpoint
31 December 2014

31 December 2014

Quick facts

Lead sponsor	Children's Hospital Los Angeles
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	treatment
Enrollment	22
Start date	1 January 2010
Primary completion	31 December 2014
Estimated completion	31 December 2014

Drugs / interventions tested

Constrain-induced Movement Therapy
Usual Occupational Therapy

Conditions studied

Neonatal Brachial Plexus Palsy — all drugs for Neonatal Brachial Plexus Palsy →

Sponsor

Children's Hospital Los Angeles

Who can join

Adults 12 Months to 5, any sex, with Neonatal Brachial Plexus Palsy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the addition of constraint-induced movement therapy (CIMT) to usual care occupational therapy in children with perinatal brachial plexus injury. Participants are randomized to receive either the intervention (CIMT) or control first, then cross over to receive the other one.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Children's Hospital Los Angeles trials

Trials by the same sponsor.

NCT07064824 — Adaptive Cell Phone Support (ACPS) · NA · not yet recruiting
NCT07508436 — Crisis Interventions for Pediatric Providers - Autism Version · NA · not yet recruiting
NCT06934655 — Early Re-Initiation of Semaglutide Post Sleeve Gastrectomy in Youth · Phase 3 · not yet recruiting
NCT07427862 — Virtual Reality (VR) for Interventional Radiology (IR) Procedures · recruiting
NCT07213908 — Comparing Two School-Based Sleep Health Interventions To Promote Sleep Quality in Youth · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03765034 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Children's Hospital Los Angeles
Last refreshed: 5 December 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03765034.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing